Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Alterome Therapeutics Inc. operates in Biotechnology & Pharmaceuticals with 1 pending office action. This matter is located in a distinct art unit. The portfolio currently shows a singular point of focus in its pending applications within the pharmaceutical sector.
The distinct examiner involved is RODRIGUEZ-GARCIA, VALERIE, who is managing 1 pending office action. This indicates that the company's current patent office interaction is limited to this specific examiner. The success of this application depends on the examiner's interpretation of the biotechnology art in this single unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RODRIGUEZ-GARCIA, VALERIE | 1 | 68.9% | +31.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18955505 | AKT1 MODULATORS | RODRIGUEZ-GARCIA, VALERIE | — |
| Art Unit | Apps |
|---|---|
| 1621 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18955505 | AKT1 MODULATORS | RODRIGUEZ-GARCIA, VALERIE | 1621 | §112 | Non-Final OA | — | Pending | Nov 21, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAlterome Therapeutics Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Valerie Rodriguez-Garcia has the most, with 1 of Alterome Therapeutics Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
